Johnson & Johnson Profit Tumbles 35% as Covid-19 Halts Sales of Medical Devices

The company, which is set to begin human trials of its experimental coronavirus vaccine this month, reported net earnings of $3.63 billion, or $1.36 per share, down from $5.61 billion, or $2.08 per share, a year earlier.

from Top Business News- News18.com https://ift.tt/2OtlN2C

• Tweet
• Share
• Share
• Share
• Share